The claim that met my eye, on Cortene's website, was, 'We believe that a short course of treatment with CT38 may be curative.' OTOH, this seems to be some sort of commercial enterprise, being (I think) a drug company, or at least one that looks for uses for drugs (?), so maybe a bit of a pinch...
"PHILADELPHIA, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE American:HEB) announced today its financial results for the third quarter ended September 30, 2017."
"We have secured our first country approval for Ampligen® in ME/CFS and we expect several more in the coming years."...
Full open paper http://adc.bmj.com/content/early/2017/09/20/archdischild-2017-313375
(Moderator note: see this post for an alternative link to the paper and links to related threads)
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.